Literature DB >> 33034192

Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge.

Javier Martín-Escolano1, Encarnación Medina-Carmona2, Rubén Martín-Escolano1.   

Abstract

Chagas disease is a neglected tropical disease and a global public health issue. In terms of treatment, no progress has been made since the 1960s, when benznidazole and nifurtimox, two obsolete drugs still prescribed, were used to treat this disease. Hence, currently, there are no effective treatments available to tackle Chagas disease. Over the past 20 years, there has been an increasing interest in the disease. However, parasite genetic diversity, drug resistance, tropism, and complex life cycle, along with the limited understanding of the disease and inadequate methodologies and strategies, have resulted in the absence of new insights in drugs development and disappointing outcomes in clinical trials so far. In summary, new drugs are urgently needed. This Review considers the relevant aspects related to the lack of drugs for Chagas disease, resumes the advances in tools for drug discovery, and discusses the main features to be taken into account to develop new effective drugs.

Entities:  

Keywords:  American trypanosomiasis; Chagas disease; Trypanosoma cruzi; chemotherapy; drug discovery; neglected tropical disease; screening cascade; target product profile

Mesh:

Substances:

Year:  2020        PMID: 33034192     DOI: 10.1021/acsinfecdis.0c00353

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  3 in total

Review 1.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

Review 2.  An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment.

Authors:  Javier Martín-Escolano; Clotilde Marín; María J Rosales; Anastasios D Tsaousis; Encarnación Medina-Carmona; Rubén Martín-Escolano
Journal:  ACS Infect Dis       Date:  2022-06-02       Impact factor: 5.578

3.  Library of Selenocyanate and Diselenide Derivatives as In Vivo Antichagasic Compounds Targeting Trypanosoma cruzi Mitochondrion.

Authors:  Rubén Martín-Escolano; Daniel Molina-Carreño; Daniel Plano; Socorro Espuelas; María J Rosales; Esther Moreno; Carlos Aydillo; Carmen Sanmartín; Manuel Sánchez-Moreno; Clotilde Marín
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.